CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- 8-K Event Regulation FD disclosure
- 4 Open-market sale CFO sold 19,345 shares at $18.04 ($348,984)
- 4 Option exercise SVP of Research, CSO acquired 1,491 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Open-market sale 10% owner sold 9,539 shares at $17.81 ($169,890)
- 4 Open-market sale 10% owner sold 9,539 shares at $17.81 ($169,890)
- 4 Open-market sale Director sold 9,539 shares at $17.81 ($169,890)
- 4 Open-market sale 10% owner sold 9,539 shares at $17.81 ($169,890)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
Page 23 of 34 · 678 filings